Anticoagulant drugs Flashcards
What are the types of disease that you’d use anti-platelets and anticoagulants for?
Coronary artery disease
Cerebrovascular disease
Peripheral vascular disease
What are the types of thromboembolic diseases that you’d just use anticoagulants for?
Atrial fibrillation
Venous thrombi-embolism (DVT, PE)
Prosthetic cardiac valves (metal)
What is virchows triad?
hyper coagulability, endothelial damage, stasis
Heparin, uses
Acute coronary syndromes Thromboembolism (prophylaxis and treatment) Venous: DVT and PE Arterial AF Warfarin replacement - pregnancy
Heparin molecules - describe
linear mucopolysaccharide chains MW very variable: 3000 - 40000 Unfracitionated heparin (IV, continuous infusion)
Unfractionated heparin
- what
- MoA
- Monitoring?
Mix of variable length heparin chains - pig intestine mucosa and bovine lung MoA - binds to and increases activity of anti thrombin III antithrombin III inactivates - thrombin (IIa) and factor Xa - and also IXa, XIa, XIIa requires APTT monitoring (blood test)
UH - pharmacokinetics
Must be given parentally (IV, SC) - negative charge, no GI absorption Rapid onset and offset of action - Short half life (<60min) - Reticuloendothelial uptake Variable bioavailability due to unpredictable binding to cells and plasma proteins - platelets (heparin neutralising protein); endothelial cells - Albumin - Needs monitoring with APTT
Unfractionated heparin, what is the therapeutic range measured on APTT
Adult reference range 25-37sec
Therapeutic range 50-80sec
Unfractionated heparin
- loading dose
- maintenance infusion
LD: - 60 units/kg (max 5000units) - give bolus dose iV - over 5 mins MD - Heparin solution 100units/ml, 25000units in 250ml saline k
commence at 12 units / kg/ hr max
titrate heparin dose appropriately vs APTT
Disadvantages of unfractionated heparin therapy
difficult complicated time consuming blood tests variable APTT control
Adverse effects of unfactionated heparin use
brusing/ bleeding
- intracranial
- Injection site
- GI loss
- Epistaxis
Thrombocytopenia (HIT)
- check platelets every 2 days
- Autoimmune phenomenon (usually 1-2 weeks of Rx)
- May bleed or get serious thromboses
- Lab assay for these antibodies
- Stop heparin
Osteoporosis with long term use
Reversal of UF heparin therapy
- Stop heparin
- If actively bleeding give protamine
- Monitor APTT if unfractionated heparin
Protamine sulphate?
- dissociates heparin from antithrombin III
- Irreversible binding to heparin
- Little effect on LMWH
About LMWH
Much more predictable in MOA and bioavailability
Smaller chains usually 4-5 Kdaltons
- generated by chemical or enzymatic depolymerisation of unfractionated heparin
Like UH have unique sequence to bind to antithrombin III
- Doesn’t inactivate thrombin IIa
- Affects factor Xa specifically
Reliable dose effect relationship
No monitoring required can measure factor Xa activity
LMWH - advantages
Better absorbed - higher bioavailability
Doesn’t bind to plasma proteins, macrophages or endothelial cells
- Loger biological half life
- More predictable dose response
- No monitoring required
Can be given Sc in an outpatient setting (teach patient how to give the dose themselves)
Lower risk of thrombocytopenia and bleeding
Safety and use during pregnancy not evaluated